|
|
40
|
|
|
50833
|
|
|
NEBIDO 250MG/ML INJ (BSP/AHI) TESTOSTERONE
|
|
|
TESTOSTERONE
|
|
|
NEBIDO
|
|
|
4ML VIAL
|
|
|
BQ
|
|
|
108.73
|
|
|
108.73
|
|
|
250MG/ML
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
BSP
|
|
|
BAYER SCHERING PHARMA AG.
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
No
|
|
|
6808
|
|
|
ANDROGENS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|